Welcome to our dedicated page for Omega Healthcare SEC filings (Ticker: OHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Omega Healthcare Investors, Inc. files regulatory documents that record its healthcare REIT results, governance and capital-structure activity. Form 8-K reports include quarterly and annual financial results, AFFO and FAD metrics, investment activity and Regulation FD exhibits tied to earnings releases.
The filing record also documents proxy matters, executive compensation disclosures, employment-agreement amendments, at-the-market common stock programs, senior unsecured credit facilities, note redemptions and the company’s NYSE-listed common stock. These disclosures frame Omega’s public reporting around long-term healthcare real estate, operator relationships, leverage and shareholder governance.
Omega Healthcare Investors Inc. (OHI) submitted a Form 144 notifying the proposed sale of 2,500 common shares through Fidelity Brokerage, with an aggregate market value of $100,900 and an approximate sale date of 08/08/2025. The filing identifies 295,000 as the number of shares outstanding in the report, which frames the proposed sale size.
The filer shows the shares were received as stock awards: 2,035 shares acquired on 06/03/2022 and 465 shares acquired on 06/10/2024, both recorded as compensation. The notice reports "Nothing to Report" for sales during the past three months and includes the standard signer representation that no undisclosed material adverse information exists.